(S) -Lisinopril-d5 (natrium)

(S) -Lisinopril-d5 (sodium) (MK-521-d5 (sodium) ) is deuterium labeled Lisinopril. Lisinopril (MK-521) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.

1356847-28-3

MK-521-d5 (sodium)

12352005

Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds

Metabolic Enzyme/Protease; Others

Cancer-programmed cell death

Cardiovascular Disease; Cancer

[2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1CC[C@@H](C(O[Na])=O)N[C@@H](CCCCN)C(N2[C@@H](CCC2)C(O)=O)=O

C21H25D5N3NaO5

432.50

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Andujar-Sanchez, M., V. Jara-Perez, and A. Camara-Artigas, Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. FEBS Lett, 2007. 581 (18) : p. 3449-54.|[3]Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41 (3) : p. 207-24.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-18206S1/

Isotope-Labeled Compounds

No Development Reported